Global Specialty Pharmaceutical Partnering Terms and Agreements 2016-2023


Global Specialty Pharmaceutical Partnering Terms and Agreements 2016 to 2023 report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals. 

Publication date
March 2023
Number of pages
Product type
Research report
Available formats
PDF document
Report edition

Global Specialty Pharmaceutical Partnering Terms and Agreements 2016 to 2023 report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals. 


This report provides details of the latest specialty pharmaceutical agreements announced in the life sciences since 2016.


The report takes the reader through a comprehensive review specialty specialty pharmaceutical deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering specialty pharmaceutical partnering deals.


The report presents financial deal term values for specialty pharmaceutical deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.


The middle section of the report explores the leading dealmakers in the specialty pharmaceutical partnering field; both the leading deal values and most active specialty pharmaceutical dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.


One of the key highlights of the report is that over 1400 online deal records of actual specialty pharmaceutical deals, as disclosed by the deal parties, are included towards the end of the report in a directory format – by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.


In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.


The initial chapters of this report provide an orientation of specialty pharmaceutical dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in specialty pharmaceutical dealmaking since 2016, including details of headline, upfront, milestone and royalty terms.


Chapter 3 provides a review of the leading specialty pharmaceutical deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.


Chapter 4 provides a comprehensive listing of the top 25 most active companies in specialty pharmaceutical dealmaking with a brief summary followed by a comprehensive listing of specialty pharmaceutical deals announded by that company, as well as contract documents, where available.


Chapter 5 provides a comprehensive and detailed review of specialty pharmaceutical partnering deals signed and announced since Jan 2016, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.


Chapter 6 provides a comprehensive and detailed review of specialty pharmaceutical partnering deals signed and announced since Jan 2016. The chapter is organized by specific technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


A comprehensive series of appendices is provided organized by specialty pharmaceutical partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.


The report also includes numerous tables and figures that illustrate the trends and activities in specialty pharmaceutical partnering and dealmaking since 2016.


In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of specialty pharmaceutical technologies and products.


Key benefits


Global Specialty Pharmaceutical Partnering Terms and Agreements 2016 to 2023 provides the reader with the following key benefits:


  • In-depth understanding of specialty pharmaceutical deal trends since 2016
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual specialty pharmaceutical contracts entered into by leading biopharma companies
  • Identify most active specialty pharmaceutical dealmakers since 2016
  • Insight into terms included in a specialty pharmaceutical partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies


Report scope


Global Specialty Pharmaceutical Partnering Terms and Agreements 2016 to 2023 is intended to provide the reader with an in-depth understanding and access to specialty pharmaceutical trends and structure of deals entered into by leading companies worldwide.


Specialty Pharmaceutical Partnering Terms and Agreements includes:


  • Trends in specialty pharmaceutical dealmaking in the biopharma industry since 2016
  • Access to headline, upfront, milestone and royalty data
  • Access to specialty pharmaceutical contract documents
  • Leading specialty pharmaceutical deals by value since 2016
  • Most active specialty pharmaceutical dealmakers since 2016


In Global Specialty Pharmaceutical Partnering Terms and Agreements 2016 to 2023, the available deals are listed by:


  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target
  • Technology type


Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.


The Global Specialty Pharmaceutical Partnering Terms and Agreements 2016 to 2023 report provides comprehensive access to available deals and contract documents for specialty pharmaceutical deals.


Analyzing actual contract agreements allows assessment of the following:


  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Global Specialty Pharmaceutical Partnering Terms and Agreements 2016 to 2023 provides the reader with the following key benefits:


  • In-depth understanding of specialty pharmaceutical deal trends since 2016
  • Access to headline, upfront, milestone and royalty data
  • Detailed access to actual specialty pharmaceutical contracts entered into by leading biopharma companies
  • Identify most active specialty pharmaceutical dealmakers since 2016
  • Insight into terms included in a specialty pharmaceutical partnering agreement, with real world examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary


Chapter 1 – Introduction


Chapter 2 – Trends in specialty pharmaceutical dealmaking


2.1. Introduction

2.2. Specialty pharmaceutical partnering over the years

2.3. Most active specialty pharmaceutical dealmakers

2.4. Specialty pharmaceutical partnering by deal type

2.5. Specialty pharmaceutical partnering by therapy area

2.6. Specialty pharmaceutical partnering by technology type

2.7. Deal terms for specialty pharmaceutical partnering

2.7.1 Specialty pharmaceutical partnering headline values

2.7.2 Specialty pharmaceutical deal upfront payments

2.7.3 Specialty pharmaceutical deal milestone payments

2.7.4 Specialty pharmaceutical royalty rates


Chapter 3 – Leading specialty pharmaceutical deals


3.1. Introduction

3.2. Top specialty pharmaceutical deals by value


Chapter 4 – Most active specialty pharmaceutical dealmakers


4.1. Introduction

4.2. Most active specialty pharmaceutical dealmakers

4.3. Most active specialty pharmaceutical partnering company profiles


Chapter 5 – Specialty pharmaceutical contracts dealmaking directory


5.1. Introduction

5.2. Specialty pharmaceutical contracts dealmaking directory


Chapter 6 – Specialty pharmaceutical dealmaking by technology type




Appendix 1 – Specialty pharmaceutical deals by company A-Z

Appendix 2 – Specialty pharmaceutical deals by stage of development

Appendix 3 – Specialty pharmaceutical deals by deal type

Appendix 4 – Specialty pharmaceutical deals by therapy area

Appendix 5 – Deal type definitions

Appendix 6 – Further reading


About Wildwood Ventures


Current Partnering

Current Agreements

Recent report titles from Current Partnering


Table of figures


Figure 1: Specialty pharmaceutical partnering since 2016

Figure 2: Active specialty pharmaceutical dealmaking activity since 2016

Figure 3: Specialty pharmaceutical partnering by deal type since 2016

Figure 4: Specialty pharmaceutical partnering by disease type since 2016

Figure 5: Specialty pharmaceutical partnering by technology type since 2016

Figure 6: Specialty pharmaceutical deals with a headline value

Figure 7: Specialty pharmaceutical deals with an upfront value

Figure 8: Specialty pharmaceutical deals with a milestone value

Figure 9: Specialty pharmaceutical deals with a royalty rate value

Figure 10: Top specialty pharmaceutical deals by value since 2016

Figure 11: Most active specialty pharmaceutical dealmakers since 2016


Pricing options


  • $3,995: single-user
  • $5,745: multi-user
  • $10,995: single site license
  • $17,995: global site license


A full explanation of license type definitions can be found here.


Our guarantee


Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.


Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)


Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.


Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.


Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.


Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

3B Pharmaceuticals, 9 Meters Biopharma, 22nd Century, 48Hour Discovery, 48North Cannabis, 111, Abacus International, Abattis Bioceuticals, Abba Import Export, Abba Medix, Abbvie, Ability Pharmaceuticals, AB InBev, Ablaze Pharmaceuticals, Abuse Deterrent Pharmaceuticals, ABX, Accord Healthcare, Accucaps, Acelrx Pharmaceuticals, Acerus, Aceto Corporation, Achieve Life Science, Aclaris Therapeutics, Acnos Pharma, Acorda Therapeutics, Acres Cannabis, Actavis (acquired by Watson), Actinium Pharmaceuticals, AcuCort, Acumen Analytics, Acura Pharmaceuticals, AdAlta, Adalvo, Adamis Pharmaceuticals, Adapt Pharma, Adare Pharma Solutions, Adastra Labs, Addex Therapeutics, Adelia Therapeutics, Adhera Therapeutics, Adhex Pharma, Adial Pharmaceuticals, Adjupharm, ADL Bionatur Solutions, Advanced Accelerator Applications, Advanced Extraction Systems, Advanced Medical Solutions, Advanz Pharma, Advent International, Advicenne, Aegis Therapeutics, Aelis Pharma, Aeon Bioscience, Aequus Pharmaceuticals, Aerami Therapeutics, Aerie Pharmaceuticals, AEssenseGrows, Aesthetic Management Partners, AEterna Zentaris, Aevum Life Science, Afaxys Pharmaceuticals, AFT Pharmaceuticals, Agalimmune, Aggrega Pharma, Agilent Technologies, Agile Therapeutics, AgMedica Bioscience, AgraFlora Organics International, AgriCann Solutions, Agritek, Agro-Greens Natural Products, Aguettant, AIDS Foundation Houston, AIkido Pharma, AimMax Therapeutics, Ainos, Aion Therapeutic, Aither Ingredient, AiVita Biomedical, Akanda, Akcea Therapeutics, Akerna, Akkadeas Pharma, Akome Biotech, Aktis Oncology, Akums Drugs and Pharmaceuticals, ALASTIN Skincare, Albany Molecular Research, Alberta Health Services, Albireo, Alcami, Alcanna, Aleafia Health, Alfasigma, Algae Dynamics, ALK-Abello, Alkemist Labs, Allegis Pharmaceuticals, Allele Genetics, Allergan, Alliance Pharma, Alliancepharma Technologies, AllianceRx Walgreens Prime, Allied Corp, Alliqua Biomedical, Alnylam Pharmaceuticals, Alphamind Brands, Alpine Hemp Group, Altan Pharma, Altasciences, Alteogen, Alternative Solutions, Alternavida, Altimmune, Altopa, Altum Pharmaceuticals, Altus Formulation, Alvit LCS Pharma, Alvogen, Alvotech, Alyvant, Amarantus BioSciences, Amarin, Ambrosia Nutraceuticals, Amend Surgical, American Regent, AmerisourceBergen, AMF Medical, Amneal Pharmaceuticals, Amomed Pharma, AMO Pharma, AMP German Cannabis, Amphastar Pharmaceuticals, Amring Pharmaceuticals, Amryt Pharma, Amyris, Amzell, Anahit, ANANDA Scientific, Angelini Pharma, AnGes MG, ANI Pharmaceuticals, Antares Pharma, AOP Orphan Pharmaceuticals, APCNA Holdings, Aperion Biologics, Apex Global Brands, Aphria, Apicore, Apipharm Veletrgovina, Apollo Green, Apollon Formularies, Apoteka, Apotex, AppianRx, Applied Biology, Applied Botanics, Applied DNA Sciences, Applied Pharmaceutical Innovation, APR Applied Pharma Research, APS Healthcare, Aptuit, Aquestive Therapeutics, Aradigm, Aralez Pharmaceuticals, Arbormentis, Arbor Pharmaceuticals, Arcadia Biosciences, Areva Med, Argentia Gold, Aries Pharmaceuticals, Arjuna Naturals, Armas Pharmaceuticals, Armetheon, Arsia Therapeutics, Arvelle Therapeutics, Asahi Kasei, Ascendent Capital Partners, Ascendia Pharmaceuticals, Ascend Therapeutics, Asceneuron, Ascent Clinical Research, Asia Green Biotechnology, ASKA Pharmaceuticals, Aspargo Laboratories, Assertio Therapeutics, AssistRx, Assuta Medical Centers, Astellas Pharma, AstraZeneca, ATAI Life Sciences, Atalo, Athena Bioscience, Athenex, Atlantic Healthcare, ATMA Journey Centers, Aucta Pharmaceuticals, Aura Biosciences, Aureuspharma, Auris Medical, Aurora Cannabis, Australian Nuclear Science and Technology Organisation, Authentic Brands Group, Auxly Cannabis Group, Avadel Pharmaceuticals, Avanos Medical, Avanzanite Bioscience, AV Cannabis, Avenue Therapeutics, Averix Bio, AveXis, Avicanna, Avida Global, Avion Pharmaceuticals, Avondale Pharmaceuticals, Avrio Biopharmaceuticals, Awakened Biosciences, AXIM Biotechnologies, Aytu BioPharma, Azanta, Azurity Pharmaceuticals, Bachem, BAMF Health, Bank of China Group Investment, BAS Research, Batavia Biosciences, Battelle, Bausch & Lomb, Bausch Health Companies, Bavarian Brewing & Beverage Institute, Bavarian Nordic, Bayer, BayMedica, Bazelet, Beckley Canopy Therapeutics, Beckley Foundation, Beleave, BellRock Brands, Ben-Gurion University, Bendalis, Bened Biomedical, Best Choice, Better Choice Products, BetterLife Pharma, Better Therapeutics, BevCanna, Bexson Biomedical, BGN Technologies, Bhang, Bill and Melinda Gates Foundation, Bio-Gate, Bio-Tissue, BioAgronomics, Bioarc, Biocept, BioCorRx, BioDelivery Sciences, Biodelta Nutraceuticals, Biohaven Pharmaceuticals, Biohit, Bio Lab Naturals, BioLab Sciences, Biolife Science, Biolinear Technologies, BiolineRX, Biological E, Biologics, Biomedical Advanced Research and Development Authority, Biopas Laboratories, Biopharmaceutical Research Company, BioPharma Services, BioQ Pharma, BioRAE, Bioscience Enterprises, BioScript Solutions, BioSyent Pharma, Biotron Laboratories, Bioventus, BioXcel, Bison & Rose, BLLRDR, Bloom Medicinals, Blueberries Medical, Blue Note Therapeutics, Blue Wolf Capital Partners, BMV Medica, BodyLogicMD, Bonify, Bophelo Bioscience & Wellness, Boston Scientific, Boston Topicals, Botanical, Braeburn Pharmaceuticals, Brains Bioceutical, Braxia Scientific, Breath of Life International, Breckenbridge Pharmaceutical, Breckenridge Pharmaceuticals, Brigham and Women's Hospital, Brill Pharma, Bristol-Myers Squibb, British Columbia Liquor Distribution Branch, BRNT, BTG, BTG Specialty Pharmaceuticals, Bunker Pflanzenextrakte, Burleigh Heads Cannabis, Bushu Pharmaceuticals, BWXT Medical, C-Tri, C4X Discovery, California Institute for Biomedical Research, Caligor, Caliva, Calliditas Therapeutics, Calyptus Pharmaceuticals, Camarus, Cambridge Commodities, Can-Fite BioPharma, Canada House Wellness Group, Canadian Institutes of Health Research, Canavation Product Group, Cancer Prevention and Research Institute of Texas, CanMart, Cannabics Pharmaceuticals, Cannabis Biocare, Cannabis Global, Cannabis House, Cannabis Manufacturer’s Guild, Cannabis Medical Solutions, Cannabis Suisse, Cannabotech, CannaBR Exports, CannAcubed, CannaCure, Cannafeels, CannaGlobal Wellness, CannaHive, CannaHoldCo, CannaKids, Cannamedical Pharma, CannAmerica Brands, Cannaponics, Cannara Biotech, CannaRoyalty, CannaSkin, CannaSoul Analytics, Cannassure Therapeutics, Cannaworx, Cannex Scientific, Cannidex Brands, Cannika, Cannim Australia, CanniMed Therapeutics, Cannomed Medical Cannabis Industries, CannRx Technology, Canntab Therapeutics, CannTrust, CannTx Life Sciences, Cannus Partners, Cannvalate, Canonic, Canopy Growth, Canopy Health Innovations, CanProbe, Cantek, Cantourage, Canymed, Cap Alter Pharma, Capcium, Capna Intellectual, Cardiovascular Solutions of Central Mississippi, Carestream Health, Cascade Pure, Cassiopea, Catalent, Catalyst Pharmaceutical Partners, CB2 Insights, CBDerma Technology, CBD Export Global, CBDistribution, cbdMD, CBD Vida, CB Therapeutics, CC Pharma, CDH Capital, Ceautamed Worldwide, CellBion, Cellen Life Sciences, Cellular Goods, Centre for Addiction and Mental Health, Centre for Human Drug Research, Centre for Probe Development and Commercialization, Centric Health Resources, CereCare, Cerecor, Cevec Pharmaceuticals, cGreen, Charles River Laboratories, Charlotte's Web, Cheetah Medical, Chemesis, Chemi Pharmaceutical, Chengdu Gaotong Isotope, Cheplapharm Arzneimittel, Chiesi Farmaceutici, China Grand Pharmaceutical, China Medical System, Chinese Academy of Sciences, Choom, Chr  Hansen, Christina Lake Cannabis, ChromaDex, Cipher Pharmaceuticals, Circassia, Ciron Drugs & Pharmaceuticals, Citius Pharmaceuticals, Citrine Medicine, CIVCO Radiotherapy, Clarion Medical Technologies, Clarity Pharmaceuticals, Clarus Therapeutics, Clearmind Medicine, Clearwater Canngrow, Clerkenwell Health, Cleveland Diabetes Care, Clinigen, Clinilabs, Clinlogix, Clionix, CloudNine, Clovis Oncology, CNBX Pharmaceuticals, Coave Therapeutics, Coeptis Pharmaceuticals, COEUS Healthcare, Coldhaus Distribution, Collegium Pharmaceuticals, Colorado Hemp Project, Columbia Care, Columbia University, Compassionate Cultivation, Compound Genetics, Concentric Analgesics, Consegna Pharma, Consilient Health, Consort Medical, Constance Therapeutics, CONTINUUS Pharmaceuticals, Convergent Therapeutics, Cooper Surgical, Core One Labs, Corporation for Biological Research, Correvio Pharma, Corvus Pharmaceuticals, Cosmofix, Cosmo Pharmaceuticals, Cream of the Crop Therapeutics, Crescita Therapeutics, Cresco Labs, Cronos Group, CR Pharma, CSL, CTC Group, Cumberland Pharmaceuticals, Curaleaf, Curavit Clinical Research, CURE Pharmaceutical, Curia, Curie Therapeutics, Curio Wellness, Curium, Currax Pharmaceuticals, Cutia Therapeutics, CVS Caremark, CV Sciences, Cybin, Cyclica, Cynapsus Therapeutics, Cyndea Pharma, Cyprium Therapeutics, Dabur, Daewoong Pharmaceutical, Daiichi Sankyo, Dalhousie University, DanCann Pharma, Danish Innovation Fund, DannCan Pharma, Dare Bioscience, DarioHealth, Dassault Systems, Debiopharm, Delic, Delpor, DelSiTech, Delta, Demetrix, Densmore Pharmaceutical, Department of Defense, Department of Health and Human Services, DePuy, Dermira, DeuteRx, Devonian Health Group, Diamond Therapeutics, Diaprost, DigiPath Solutions, DionyMed Brands, Diurnal, Diverchim, Divergence Neuro Technologies, DKSH, DKT, Docklight Brands, DolCas-Tenshi Bioceuticals, DolCas Biotech, Dompe Farmaceutici, Dona Blanca, Dosecann, DoubleRainbow Biosciences, Dow Chemical, Dr. Reddy's Laboratories, Dragonfly Biosciences, Dreamy, Dr Kerklaan Therapeutics, Dr Pfleger, DSG, DS Healthcare, DSM, Duchesnay, Duke-NUS Graduate Medical School Singapore, DuPont, Durbin Group, Durect, Dutch Emotional Brain, Dutch Passion Seed Company, DynamiCARE, Dynavax Technologies, Eagle Pharmaceuticals (US), EA Pharma, Easton Pharmaceuticals, Ecobrands, Ecogen, Eczacıbasi-Monrol, Eddingpharm, Edenbridge Pharmaceuticals, Edge Pharma, Edison Nation, Editas Medicine, EffRx, Egalet, Ei.Ventures, Eiger BioPharmaceuticals, EirGen Pharma, Eisai, Eldan, Eleusis, Elevar Therapeutics, Eli Lilly, Elite Pharmaceuticals, Elorac Pharma, Embark Health, Embera NeuroTherapeutics, Emerald Family Farms, Emerald Health Therapeutics, Emerald Organic Growth, Emerge Health, EMMAC Life Sciences, Emmaus Medical, Empower Clinics, Empyrean Medical Systems, EMS, Encore Dermatology, Encore Life, Endocanna Health, Endo International, EndoLogic, Enosis Therapeutics, Entheon Biomedical, Enthusiasmus, Entoura, Entourage Health, Entourage Phytolab, Entrada Therapeutics, Enveric Biosciences, EnWave, Enzymotec, EPI Health, Er-Kim, Erytech, ESJ Enterprises, Espero Biopharma, Estar Medical, Esteve, Ethicann Pharmaceuticals, Ethypharm, EUSA Pharma, Eve & Co, Everest Medicines, Evergreen Theragnostics, Eversana, Evoke Pharma, Evolution Research Group, Ewopharma, Exactus, ExCEEd Orphan, Exela Pharma Sciences, EXMceuticals, Exotic Genetix, Experion Biotechnologies, Express Scripts, Eybna Technologies, EyeCare Services Partners, EyeCRO, Eyegate Pharmaceuticals, Eyenovia, EyePoint Pharmaceuticals, Eyevance, Fagron, Fannin, Farco Pharma, Farmacias Magistrales, Farmalider, FarmaMondo Group, FCM Global, Fedecore, Feel Better, Feel Ventures, Fermentalg, Filament Health, Fine Foods & Pharmaceuticals N.T.M., Finzelberg, Fission Labs LATAM, Flexion Therapeutics, Flowerkist, Flower One, Fluence, Fluence Bioengineering, Fluum, Flynn Pharma, Foamix Pharmaceuticals, Focus-X Therapeutics, Focus Laboratories, Food and Drug Administration (FDA), ForDoz Pharma, Formosa Pharmaceuticals, Fosun Pharmaceutical, Four 20 Pharma, Fox Chase Cancer Center, Freya Pharma Solutions, Front Range Biosciences, Frost Pharma, Fruit Slabs, FSD Pharma, Fudan University, Fujifilm, Fujifilm Kyowa Kirin Biologics, Full-Life Technologies, Full Spectrum Biosciences, Fusion Pharmaceuticals, Futura Medical, FutureChem, Fuzionaire, Fuzionaire Diagnostics, Fuzionaire Radioisotope Technologies, Gad Medical Equipment, Gage Cannabis, Gaia, Galderma, Galen, Galenicum Health, Gallery Brands, GAMA, GB Pharma Holdings, GB Sciences, Gebro Pharma, GE Healthcare, Gelesis, Genco Sciences, Genentech, GeneQuine Biotherapeutics, General Extract, Generex Biotechnology, GeniusRx, Genomix Scientific, Geocann, George Mason University, Gesval, GetHealthy, Gideon Pharmaceuticals, Ginkgo BioWorks, Gland Pharma, Glaukos, GL Brands, GL Capital Group, Glenmark Pharmaceuticals, Glenmark Pharmaceuticals S.A., Global Cannabinoids, Global Canna Labs, Global Damon Pharma, Gnosis Bioresearch, go NXT LVL, Good & Green, Government of Canada, Grace Fine Chemicals, Graminex, Grand River Aseptic Manufacturing, Graystone Company, Great North Distributors, Greene Street Pharmaceuticals, Green Gorilla, Greenstein Germany, Green Stripe Naturals, Greenteaspoon, Grenco Science, GroupHEALTH Benefit Solutions, Grove Collaborative, GroVida, Grow Biotech, Grunenthal, Grupo Curativa, Grupo Farmaceutico Somar, GSW Creative Corporation Canada, GTCR Golder Rauner, GTEC Holdings, GTP Technology, GT Research, Guerbet, Gupta Pharma, Gurnet Point Capital, GVB Biopharma, GVK Biosciences, GW Pharmaceuticals, H2-Pharma, HAI Health, Haisco Pharmaceutical, Halo Labs, Halucenex Life Sciences, HaluGen Life Sciences, Hamilton Health Sciences, Hammock Pharmaceuticals, Hanfpost, Hannover Medical School, Hansa Biopharma, HanX Biopharmaceuticals, Hao Le Ku (Beijing) Infant And Maternity, Harm Reduction Therapeutics, Harris, Harvest One, Havn Life Sciences, Health Box, Healthcare Royalty Partners, Health Decisions, Health House International, HealthTech Connex, HealthWarehouse, Healthy Grain, HeavenlyRx, Helmholtz Zentrum Munchen, Helsinn Healthcare, HemispheRx Biopharma, HempFusion Wellness, Hempsana, HemPup, Herbolea Biotech, Heritage Cannabis, Heritage Pharmaceuticals, Heumann Pharma Generics, Hexo, Hi-Tech Pharmaceuticals, Hibernation Therapeutics, High Beauty, Highland Pharmaceutical, High Performance Nutrition, High Tide Ventures, HLH BioPharma Vertriebs, HLS Therapeutics, HMNRTH, Hofseth BioCare, Holigen, Hollister Biosciences, HollyWeed North Cannabis, Honor Epic Enterprises, Horizon Pharma plc, Hormosan Pharma GmbH, Hoth Therapeutics, Human Biosystems, Humanetics, Huntsman, HUYA Bioscience, Hybrid Pharm, Hyloris Pharmaceuticals, Hypha Wellness, Hyris, Hyundai Pharmaceutical, I-Bridge Capital, IACTA Pharmaceuticals, iAnthus Capital, IBA, IBA Molecular Imaging, iBrands, ICAN, ICL, Iconic Brands, Ideogen Pharma, Idera Pharmaceuticals, IDIPharma, Ikanik Farms, Ilera Holistic Healthcare, Ilera Therapeutics, IM Cannabis, Immune Therapeutics, ImmuNext, Imperial Brands, Imperial College London, Impilo Pharma, Impopharma, Impression Healthcare, Imprimis Pharmaceuticals, ImprimisRx, Incannex Healthcare, Inceptua, Indegene Lifesystems, India Colorada, India Globalization Capital, Indivior, InfaCare, InfuSystem Holdings, InfuTronix Solutions, Inhibrx, Initiator Pharma, InMed Pharmaceuticals, Innocoll, InnoPharmax, Innospec, Innova Biosciences, Innovate Biopharmaceuticals, Innovus Pharmaceuticals, Inolife Technologies, Insmed Inc, Inspirion Delivery Sciences, Intas Pharmaceuticals, Intec Pharma, Integrated Cannabis Company, Integrative Medicine, IntelGenx, Intercontinental Marketing, InterCure, International Medication Systems, International Research Center on Cannabis and Mental Health, Intrexon, IntuitiveX, Invagen, Invekra, Invetech, Invictus MD Stategies, Ionetix, Ionic Brands, ipCapital Group, Ipsen, IPS Specials, iQone Healthcare, IriSys, Ironshore Pharmaceuticals, Irwin Naturals, IsCann Group, ISIS Innovation, Island Garden, Isologic Innovative Radiopharmaceuticals, Isosceles Pharmaceuticals, Isotopia Molecular Imaging, IthenaPharma, ITM Isotopen Technologien, iX Biopharma, J&H, Jabez Pharma, Jacksonville Pharmaceuticals, Jade Therapeutics, Jaguar Health, Jamieson, JAMP Pharma Group, JanOne, Janssen Pharmaceutica NV, Japan Medical Isotope Technology Development, Jazz Pharmaceuticals, Jennewein Biotechnologie, Jerome Stevens Pharmaceuticals, Jianming Pharmaceutical, Johns Hopkins University, Journey Medical, Jungle Med, Jupiter Orphan Therapeutics, Jupiter Wellness, JustCBD, Juvise Pharmaceuticals, Kadenwood, Kaivalya Kollectiv, Kali-Extracts, Kanabo Research, Kaneh-B, Karo Pharma, Kashiv BioSciences, Kayagene, Kazmira, KC Pharmaceuticals, KD Pharma, Kelai Pharmaceuticals, Kemin Industries, KemPharm, Kensing, Kensington Pharma, Keygene, KGK Science, Khalifa Kush Enterprises, Khandelwal Laboratories, Khiron Life Sciences, Khon Kaen University, Khrysos Industries, Kindeva Drug Delivery, Kindred Partners, Klaria, Knighton Foods, Knight Therapeutics, Kombucha Baby Brewing Company, Komtur Pharmaceuticals, Kowa, Koyo Foods, KSF Acquisition, Kubota Vision, Kyowa Hakko Kirin, L'Oreal, L-3 Communications, Laboratoires DELBERT, Laboratoire Serb, Laboratoires Thea, Laboratorios Adler, Laccure, Landrace Bioscience, Lannett, Launchit Ventures, Lavie Bio, Lawley Pharmaceuticals, Leading Edge Pharms, Legacy Biotechnologies, Leiters, Leonard-Meron Biosciences, LEO Pharma, Leriva, Les Laboratoires Servier, Leukocare, Levitee Labs, Liberty Health Sciences, LifeCell, Lifestyle Delivery Systems, Life Time, Lighthouse Strategies, Lightlake Therapeutics, Liiv Organics, Limbix, Lipidor, LipoCure, Livzon Pharmaceutical, Lobe Sciences, Lobo Genetics, Los Altos Pharmaceuticals, Lotus Pharmaceuticals, LOVE Pharma, LTS Lohmann Therapie-Systeme, Lucid Psycheceuticals, Lukare Medical, Lumicera Health Services, Lumiera Health Innovation, Luminarie, Lunatus, Lune Rise Farms, Lupin, Lupin Pharmaceuticals, Luqa Pharmaceuticals, LYF Food Technologies, Lygos, Lyndra Therapeutics, Maastricht University, MaaT Pharma, Magdalena Biosciences, MagicMed Industries, Magnolia Extracts, MainPointe, Mallinckrodt Pharmaceuticals, Maple Leaf Green World, Maplex Naturals, Marina Biotech, Marinus Pharmaceuticals, Martindale Pharma, Maruho, Massachusetts General Hospital, Mass General Brigham, Mast Therapeutics, Materia, Mawson Infrastructure, Maxhealth Medicine, Maxor National Pharmacy, Mayne Pharma, MBioTeQ, McGill University, McKesson, McMaster University, McNeil Consumer Pharmaceuticals, MD Anderson Cancer Center, Mechelen, Med-Aesthetic Solutions, Medac, Medacta, Medara, Medcolcanna Organics, Medexus Pharmaceuticals, Medherant, Medical Cannabis by Shoppers, Medical Marijuana, Medican Enterprises, Medicanmentos de Cannabis, MediCann Handels, MedicaSafe, Medicinal Genomics, Medicines360, Medicure, Medifirst Solutions, MedImpact Direct, MediPharm Labs, Medisca, MediSynergics, Medocann Pharma, MedPharm, MedReleaf, Med Tech Farms, Megalabs, Megapharm, Melorganics Hellas, Memorial Sloan Kettering Cancer Center, MenoLabs, Merck and Co, Merck KGaA, Meroven, Merrimack Pharmaceuticals, MetaMe Health, Methapharm, MetP Pharma, Metuchen Pharmaceuticals, MGC Pharma, Michael J Fox Foundation, Michigan State University, MicroDoz Therapy, Micro Labs, MilanaPharm, Millennium, MIND Foundation, Mind Medicine, Mindset Pharma, MindShift Compounds, Mino Labs, Miravo Healthcare, Mirum Pharmaceuticals, MISTR, Mithra Pharmaceuticals, Mitsubishi Tanabe Pharma, Mitsui, MMJ PhytoTech, MM Technology, Moberg Pharma, Moeller Pharma, Molecular Targeting Technologies, Molteni Farmaceutici, Monash University, Mondias Natural Products, Monopar Therapeutics, Monosol LLC, MonoSolRx, MonoSol Rx, Montreal Cannabis Medical, Mor Research Applications, Mota Ventures, Mountain Valley MD, Moyer Foundation, MPB Group, MPX International, MSC, MTP Material, Mundipharma, MycoMeditations, Myconic Capital, Mycotopia Therapies, Mycrodose Therapeutics, Mydecine Group, Mylan Laboratories, Mylan Pharmaceuticals, MYM Nutraceuticals, MYND Life Sciences, MyoKardia, MYOS, myTomorrows, Naari Pharma, Nabis, Nabriva Therapeutics, Nacuity Pharmaceuticals, Nalu Bio, Namaste Technologies, Nanoform, Nanomerics, Nanopharmaceutics, Nanosphere, NanoSphere Health Sciences, Nanotherapeutics, NASA, National Center for Complementary and Integrative Health, National Green Biomed, National Institute of Allergy and Infectious Diseases, National Institute of Standards and Technology, National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), National Institutes of Health, National Kapodistrian University of Athens, National Science Foundation, Natural Sciences and  Engineering Research Council of Canada, Navamedic, Navigo Proteins, Navitas, Neauvia North America, Nemaura Pharma, NEMUS Bioscience, Neobiomics, NeonMind Biosciences, Neos Therapeutics, Neox, Nephcentric, Nephron Dx, Neptune Wellness Solutions, Nestle Health Science, NetCann, Neumentum, Neuraxpharm, Neurim Pharmaceuticals, Neurogastrx, NeuroPharm, NeuroproteXeon, NeuroTheryX, Nevada Center For Behavioral Health, New Age Nanotech, NewCanna Hub, NewFaDem, NewLeaf Brands, New Leaf Canada, Newly Institute, New Path Laboratories, New York State, Nextage Therapeutics, Next Frontier Biosciences, Next Frontier Pharmaceuticals, Nextleaf Solutions, Nextmune, NFL Biosciences, NHL Alumni Association, Nicoya, Nimbus Health, NineteenGale Therapeutics, Niowave, Nirvana Life Sciences, Nissan Chemical Industries, NLS Pharmaceutics, Noble Growth, Node Labs, Noden Pharma, Noramco, Nora Pharma, Nordic Pharma Group, Nordion, Norgine, NorthStar Medical Radioisotopes, Novaliq, Nova Mentis Life Science, Novamind, Novan, Novartis, Novasep, Novo Integrated Sciences, Novos Patient Solutions, Nrgene, NTC, Nuance Pharma, Nucliber, Numedicus, NuMedii, Numinus Wellness, Nurosene, NutraGyst, Nutrasource Pharmaceutical, Nutrawise Health & Beauty, Nutriband, Nutrilinea, Nutrition21, Nuvisan Pharma Services, NXTGEN, NYU Grossman School of Medicine for Preclinical and Clinical Research, NYU Langone Medical Center, Obvious Ventures, Ocean Grown Ventures, Oculus Innovative Sciences, Ocumension Therapeutics, ODI Pharma, OETTINGER Brauerei, OG DNA Genetics, OG Laboratories, Ohio State Innovation Foundation, Oklahoma Medical Research Foundation, Olympus Medical Systems, Omega Bittner, Omni Medical Products, OncoGenex Pharmaceuticals, Onconova Therapeutics, OneLife Botanicals, One Small Planet, One World Pharma, Ontario Cannabis Retail, Ontario Clinical Oncology Group, Onxeo, Open Book Extracts, Ophirex, Opiant Pharmaceuticals, Opiostop, OPKO Health, OptiBiotix, Opticann, Optima Pharmazeutische, Optimi Health, OptiNose, Optum Frontier Therapies, Or-Genix Therapeutics, Ora, Orbis, Orbis Biosciences, Orbus Therapeutics, Oregon Health Sciences University, Orexigen Therapeutics, Orexo, Organic Remedies, Organigram, Organogenesis, Orion, OrphanDC, Orpharm, Orsini Healthcare Specialty Pharmacy, Orthopaedic Research and Education Foundation, Osmotica Pharmaceuticals, Otifex Therapeutics, Ovation Science, OVID Health Systems, OWC Pharmaceutical Research, OWP Pharmaceuticals, Oxford Pharmaceuticals, Pacific Sun Fungi, Pacira Biosciences, Padagis, Pain Therapeutics, Palatin Technologies, Panaxia, PANTHERx Specialty Pharmacy, PanTheryx, ParcelShield, Parent Company, Parkinson's Disease Foundation, Park Therapeutics, Particle Dynamics, Pascal Biosciences, Pasithea Therapeutics, Pathway Health, Pathway Rx, Pax Labs, PDL BioPharma, Peak Health Center, Peak Performance Products, Peak Pharm Labs, PEAR Therapeutics, PegBio, PellePharm, Pendopharm, PeptiMimesis, Peptron, Perennial, Pernix Therapeutics, Perrigo, Petalfast, Petros Pharmaceuticals, Pfizer, Phagenesis, Pharmabiota, PharmaCielo, PharmaDrug, Pharmadrug Production, PharmaEngine, PharmaHemp, PharmaLynk, PharmaMar, Pharmanest, Pharmanovia, Pharmascience, Pharma Solutions Peru, Pharmastrip, PharmaSwiss, Pharmathen, PharmaTher, Pharmatronic, PharmHouse, Pharmicated, Pharming Group, Phil, Philadelphia College of Osteopathic Medicine Foundation, Philip Morris, Philochem, Phlo, Phlow, PhotoMedex, Photonamic GmbH, PH Precision Med, Phylloceuticals, Phyto Animal Health, Phyto Extractions Brands, Pilz Bioscience, Pint Pharma, Pioneer Knop Laboratorios, PIPStek, Piramal, Pivot Pharmaceuticals, Planet Green BioTechnology, PlantEXT, Pleasure Peaks, Pleco Therapeutics, Plena Global, Plus Therapeutics, Pneuma Respiratory, Pohl Boskamp, POINT Biopharma, PolyPid, Population Council, Poxel, Pragma Pharmaceuticals, Precirix, Precisa Medical Instruments, Precision Molecular, Premier Biomedical, Premier Inc, Premium 5, Pressure BioSciences, Prime Therapeutics, Primex Pharmaceuticals, Primm Pharma, Primo Nutraceuticals, Procaps, Profile Solutions, Progenics Pharmaceuticals, Project Cannabis, Promises Innovative Recovery Center, Promius Pharma, ProPharma Group, Prophase Labs, Prosoma Digital Therapeutics, Provecs Medical, Provepharm, Province of British Columbia, Psirenity, PsyBioMed – Australia, Psychedelic Society Belgium, Psyence Therapeutics, Psygen Labs, Public Health England, Pura Naturals, Puration, Purdue Pharma, Pure Cannabis Research, Pure Extracts Technologies, PureForm Global, Pure Origin, Purisys, Purna Pharmaceuticals, Pyramid Biosciences, Q BioMed, QoL Medical, Quadri Pharmaceuticals, Quanta, Quinta-Analytica, Quoin Pharmaceuticals, Quotient, Radiancy, Radient Technologies, Radiomedix, Radiopharm Theranostics, Radiopharm Ventures, Rafa Pharmaceuticals, Rafarma Pharmaceuticals, Rapid Dose Therapeutics, RavenQuest BioMed, RayzeBio, RCK, RCS International Investments, RDD Pharma, Real Brands, Realm of Caring, Rebel Edibles, Recipharm, Recover Together, Redbarn Pet Products, RedHawk, RedHill Biopharma, Red White & Bloom Brands, Regencell Bioscience, Regeneron Pharmaceuticals, ReLeaf Europe, Relief Therapeutics, Relmada Therapeutics, Renaissance Acquisition Holdings, Reneo Pharmaceuticals, REPO4EU, Repurpose.AI, Reset Pharmaceuticals, Respira Technologies, Respira Therapeutics, Reverie Labs, Reverie Psychedelics, ReVision Optics, REVISS Services, Revive Therapeutics, Reyon Pharmaceuticals, Rhinomed, Rho, Rhoshan Pharmaceuticals, Rigour International, Rise Wellness, River Vision Development, Roche, Rocket VR Health, Rocky Mountain Marijuana, Ro Invest, ROMEG Therapeutics, Rougier Pharma, RS BioTherapeutics, Rubicon Research, RX Pharmatech, Ryerson University, Sabal Therapeutics, SABI Mind, SACCO, Safer Medical of Montana, Safe Sea, Sagely Enterprises, Sairiyo Therapeutics, Salvation Botanicals, Sandhill One, Sandoz, Saniona, Sanofi, Sanpellegrino Cosmetics, Sansero Life Sciences, Sante Laboratories, Saol Therapeutics, SastoMed, Satipharm, Sato Pharmaceutical, Savara Pharma, Scandinavian Health, SciCann Therapeutics, SciClone Pharmaceuticals, Sciecure Pharma, Sciensus Rare, Scientific Research Council, Scilex Pharmaceuticals, SciSparc, Scopus BioPharma, Scripps Research Institute, Searchlight Pharma, Secarna Pharmaceuticals, Sedor Pharmaceuticals, Seedo, Seelos Therapeutics, Segra International, Seibersdorf Laboratories, Selexis, Sen-Jam Pharmaceutical, Sensus Healthcare, Sentynl Therapeutics, Seqirus, Sera Labs, SERB Pharmaceuticals, Serendex Pharmaceuticals, Seren Pharmaceuticals, Shanghai Dahua Pharmaceutical, Shanghai Hi-Tech Nutraceuticals, Shanti Therapeutics, Shanxi Yabao Pharmaceutical Distribution, Shefield and Sons, Shield Therapeutics, Shionogi, Shire Pharmaceuticals, Shoppers Drug Mart, Shorla Pharma, Short Wave Pharma, ShroomBloom, Sidero Bioscience, SIFI (Societa Industria Farmaceutica Italiana), Sigma-Tau, Silo Pharma, Silo Wellness, Sinovant Sciences, SI Pharmaceuticals, Siva Therapeutics, Skinvisible, SkyePharma, Slayback Pharma, Sloan Pharma, Smart for Life, Smart Supplement, SMG Pharmaceuticals, SNDL, Societe des alcools du Quebec, Soin Neuroscience, Soin Therapeutics, Solaris, Soligenix, Soluble Systems, Sona Nanotech, Sonendo, Sonoma Pharmaceuticals, Sophos Biotech, Sorrento Therapeutics, Sorse Technology, Sound Pharmaceuticals, Sourasky Medical Center, Southern Cross University, Southern Glazer's Wine & Spirits, Southwest Research Institute, Sparsha, Spaulding Clinical Research, Spectrum Health, Spectrum Pharmaceuticals, Spenta, Spore Life Sciences, Sproutly, SRS Life Sciences, STADA Arzneimittel, Stalicla, Stanley Capital, Starbuds, Stark Investments, Starpharma, Starseed, Steep Hills Labs, Stem Holdings, Stenocare, Sterigenics, Steriscience, Stevanato, Stevens Green, StillCanna, Stratatech, Strategic Science and Technologies, Stratpharma, Strides Pharma Science, Strongbridge Biopharma, STU, Sugarbud Craft Growers, SugarLeaf Labs, Summit Biosciences, Sundaily, Sunderstorm, Sundial Growers, SunGen, Sunny Pharmtech, Sunovion Pharmaceuticals, SUNY Upstate Medical University, Supernus Pharmaceuticals, Supreme Cannabis, Supreme Pharmaceuticals, Supriya Lifescience, Surterra Wellness, Suzuken, Swedish Orphan Biovitrum, Swinburne University, Swing Therapeutics, SWK Funding, Swysh, SYGNIS Pharma, SymbioPharm, Symeres, Synbiotic Health, Synergy Aesthetics, Synthonics, Syqe Medical, TAAT Lifestyle & Wellness, Tactical Relief, TAE Life Science, TaGeza Biopharma, Taiho, Takeda Pharmaceutical, Tandem Diabetes Care, Tanner Pharmaceuticals, Tanon, Tantalus Labs, TargEDys, Targeted Pharmaceutical, Target Group, Taro Pharmaceuticals, Tasman Pharma, Taste-T, Tauriga Sciences, Technion Research and Development Foundation, Teijin, Tel Aviv University, Telix Pharmaceuticals, Tenacia Biotechnology, Tenax Therapeutics, Tenshi Kaizen, Terrace Global, Terragenx, TerraPower, TerrAscend, TerSera Therapeutics, Tesaro, TesoRx Pharma, Tetra Bio-Pharma, Tetraphase Pharmaceuticals, Tetris Pharma, Teva Pharmaceutical Industries, Thar Process, The Alchemists Kitchen, The Green Organic Dutchman Holdings, The Kroger, The Medicines Company, The Nutraceutical Medicine Company, TheraCann International Benchmark, Theragnostics, Therakine, Theramex, TherapeuticsMD, Therapeutic Solutions International, Therapix Bio, Theratechnologies, Therios Healthcare, Therismos, The Technical University Of Munich, Thorne HealthTech, Thrive Cannabis, Tikun Olam, Tikun Olam-Cannbit, Tilray, Tioga Research, Titan Pharmaceuticals, Tiva Bio, TLC BioSciences, Tobira Therapeutics, Together Pharma, Toronto Centre for Psychedelic Science, Toronto Innovation Acceleration Partners, Transcend Biodynamics, Transcoject, Translational Medicine Accelerator, TrialSpark, Trident Brands, Trigen, Tris Pharma, Tritium 3H, TRIUMF, TRON Group, TRP, True North Cannabis, Trulieve, TryptageniX, Tryp Therapeutics, Tsime Pharmaceuticals and Medicinal Supplies, TWi Biotechnology, TwinPharma, Ultragenyx Pharmaceuticals, Uni-Bio Science, Union Springs Pharmaceuticals, United Greeneries, United States Pharmacopeia, United Therapeutics, Univar, Universal Ibogaine, Universidad CES, University Health Network, University of Antwerp, University of Arizona, University of British Columbia, University of Calgary, University of California Berkeley, University of California Los Angeles, University of Cincinnati, University of Colorado, University of Guelph, University of Health Sciences Antigua, University of Leuven, University of Maryland Baltimore, University of Miami Miller School of Medicine, University of Michigan, University of Mississippi, University of Nebraska, University of Oxford, University of Rochester Medical Center, University of Saskatchewan, University of Sherbrooke, University of Toronto, University of Washington, Univo Pharmaceuticals, Unravel Biosciences, Up Cannabis, Uppsalagruppen Medical, Upsher-Smith, US Army, US Bioservices, US Government, UTILITY Therapeutics, Valbiotis, Valeant Pharmaceuticals, Valens Company, Valneva, Vanguard Scientific Systems, Vapium, Vault Health, Vaxil BioTherapeutics, VAYA Pharma, VB Brands California, VDM Biochemicals, Vector Institute, Vectura, Vektor Pharma, Veloxis Pharmaceuticals, Ventis Pharma, Verde Leaf, VerdePharmHealth, Verinetics, Veritas, Verity Pharmaceuticals, Verix, Vernalis, Verse Cannabis, Vertical Companies, Vertical Pharmaceuticals, Veterans For Healing, ViaDerma, Vici Health Sciences, Vida Concepts, Vifor Pharma, Viramal, Virginia Tech Carilion Research Institute, Viridian Pharma, Viridian Sciences, Virpax Pharmaceuticals, Vision Essence, VitaDairy, Vitae Naturals, Vital Food Processors, Vital Proteins, VivaCell Biotechnology Espana, Vivelix Pharmaceuticals, VIVO Cannabis, Vivus, Vocan Biotechnologies, Voisin Consulting Life Sciences, vTv Therapeutics, Vygoris, VYNE Therapeutics, Vyripharm, Walter Reed Army Institute of Research, Wanbang Biopharmaceuticals, WardMM, Wayland, WB Canna & Wellness, WeedMD, WEP Clinical, Werc Shop, WholeScripts, Willow Biosciences, Windgap Medical, Windsor Pharmaceuticals, Winhealth Pharma Group, Woolsey Pharmaceuticals, World Class Extractions, World Orphan Drug Alliance, Worldwide Clinical Trials, Wuhan General Group, Wuhan Humanwell, Xbrane Bioscience, Xellia Pharmaceuticals, XERIS Pharmaceuticals, XL-Protein, XLR8 Brazil, XPhyto Therapeutics, Yield Growth, Yifan Pharmaceutical, Yiling Wanzhou International Pharmaceuticals, Yissum Research Development, Yom Chai, Youngevity, Yukon Medical, Yummi Karma, YVY Life Sciences, ZAI Laboratory, ZappRx, Zelira Therapeutics, Zeltiq Aesthetics, Zenabis, Zerion Pharma, Zhejiang Yonghe Pharmaceutical Technology, Zion Medical, Zuellig Pharma China, Zylo Therapeutics, ZYUS Life Sciences, ZyVersa Therapeutics

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!